BRECISE Overview
- Website
- brecise.eu
- Industry
- Biotechnology Research
- Employees
- 126
- Funding
- ,
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About BRECISE
BRECISE is a five-year research project accelerating the clinical validation of AI-driven, NGS-based biomarkers in prostate and bladder cancer. It aims to support personalized treatment, improve patient outcomes, and enable integration into European healthcare systems. This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No. 101194784. The JU receives support from the European Union’s Horizon Europe programme, COCIR, EFPIA, EuropaBio, MedTech Europe, and Vaccines Europe.
Compare Similar Companies to BRECISE
Innovative Health Initiative (IHI)
Research Services
Genomate Health
Health And Human Services
UCEC
Education Administration Programs
OHMX.bio
Biotechnology Research
Fundación OncoSur
Non-Profit Organizations
MWP4SPACE
Space Research And Technology
BIOMAP IMI
Research Services
eTRANSAFE
Research Services
PANCAID
Research Services
SInISA
Public Health